阴道和宫颈透明细胞腺癌的发病率与风险:40年随访更新
研究回顾芝加哥大学透明细胞腺癌登记库至2014年的720例病例,其中420例有产前己烯雌酚(DES)暴露证据。DES相关透明细胞腺癌风险在1951-1956年出生队列最高,与当时美国DES处方量高度相关(r=0.98,P=0.005);至50岁时每750名暴露女性中累积风险为1例,纳入部分暴露证据阴性病例后升至每520名中1例。
要点
- DES相关透明细胞腺癌80%发生于15-31岁,但最晚至55岁,42岁左右可见小第二个峰。
- 1951-1956年出生队列风险最高,该出生队列效应与美国DES处方量随时间变化高度相关(r=0.98,P=0.005)。
- 至50岁时DES相关透明细胞腺癌累积风险为每750名暴露女性中1例,纳入暴露证据阴性病例后为每520名中1例。
核心结论
- 研究证实产前DES暴露与透明细胞腺癌相关,并细化了DES相关透明细胞腺癌的风险。
研究设计与样本
- 回顾芝加哥大学透明细胞腺癌登记库至2014年的720例透明细胞腺癌病例,基于1948年至1971年出生的美国白人女性计算发病率和累积风险。
主要发现
- 420例有产前DES暴露证据,其中80%发生于15-31岁,但部分晚至55岁,42岁左右出现小第二个峰。
- DES相关透明细胞腺癌风险在1951-1956年出生队列最高,该出生队列效应与美国DES处方量随时间变化高度相关(r=0.98,P=0.005)。
- 至50岁时DES相关透明细胞腺癌累积风险为每750名暴露女性中1例。
- 无DES暴露证据的透明细胞腺癌病例在年龄、诊断年份和出生队列模式上与有记录DES暴露病例相似,提示部分阴性病例实际有暴露,纳入后累积风险升至每520名中1例。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Women exposed to diethylstilbestrol (DES) in utero are at increased risk for the development of vaginal and cervical clear cell adenocarcinoma (CCA) at younger age. It is unknown if a second peak will occur in later life, the ages when CCA developed spontaneously in the pre-DES era. The complete epidemiologic curve of CCA has not been reported, yet. METHODS: We reviewed 720 cases of CCA from the CCA registry at the University of Chicago through 2014. Incidence rates and cumulative risks for CCA were calculated based on white women born in the U.S. from 1948 through 1971. RESULTS: In 420 CCA cases there was documented evidence of prenatal DES exposure. 80% were among those between ages 15 and 31 but some occurred as late as age 55. A small second peak occurred around age 42. The risk of DES-related CCA was highest in the 1951-1956 birth cohort and this birth cohort effect closely correlated with DES prescriptions over time in the U.S. (r=0.98, P=0.005). By age 50, the cumulative risk of CCA was 1 per 750 exposed women. CCA cases without evidence of DES exposure had similar ages, year of diagnosis, and birth cohort patterns as the documented DES-exposed cases, suggesting that some negative cases were exposed. Their inclusion raises the cumulative risk of CCA to 1 per 520. CONCLUSION: With the largest data available, our results confirmed the association between prenatal DES exposure and clear cell adenocarcinoma. The study also refines the risks of DES-related CCA.
引用
- Huo D, Anderson D, Palmer JR, et al. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up. Gynecol Oncol. 2017. PMID: 28689666. doi:10.1016/j.ygyno.2017.06.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。